DIAGNOSIS AND TREATMENT OF MODERATE COGNITIVE IMPAIRMENT
Varying degrees of cognitive disorders are observed in about 70% of patients over 60 years of age. Early detection of cognitive disorders at non-dementia stages contributes to timely pathogenetic therapy. The paper describes diagnostic criteria for moderate cognitive impairment (MCI), its epidemiology, etiology, clinical manifestations, study methods, and therapy in patients with MSI syndrome. Key words: cognitive disorders, dementia, moderate cognitive impairment syndrome, neuroprotector therapy